3
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Parathyroid Function in Relation to Intestinal Function and Renal Calcium Reabsorption in Patients with Nephrolithiasis

, , , , &
Pages 55-64 | Received 25 Jun 1990, Accepted 18 Jan 1991, Published online: 15 Feb 2010

REFERENCES

  • Ashby JP, Loveridge N, Brown RC, Zanelli JM, Rinsler MG, Watts RWE. Anomalies in the assay of parathyroid hormone in normocalcaemic patients with renal stone disease. Clin Endocrinol 1988; 29: 131–140.
  • Backman U, Danielson BG, Fellström B, Johansson G, Ljunghall S, Wikström B. Biochemical and clinical effects of the prophylactic treatment of renal calcium stones with magnesium hydroxide. J Urol 1980; 124: 770–774.
  • Backman U, Danielson BG, Johansson G, Ljunghall S, Wikström B. Incidence and clinical importance of renal tubular defects in recurrent renal stone formers. Nephron 1980; 25: 96–101.
  • Benson L, Ljunghall S, Groth T, Falk H, Hvarfner A, Rastad J, Wide L, Åkerström G. Optimal discrimination of mild hyperparathyroidism with total serum calcium, ionized calcium and parathyroid hormone measurements. Uppsala J Med Sci 1987; 92: 147–176.
  • Bijvoet OLM. Relation of plasma phosphate concentration to renal tubular reabsorption of phosphate. Clin Sci 1969; 37: 23–36.
  • Caspary WF. Intestinal oxalate absorption. Res Exp Med 1977; 171: 13–24.
  • Coe FL, Bushinsky DA. Pathophysiology of hypercalciuria. AM J Physiol 1984; 247: F1–F13.
  • Coe FL, Canterbury JM, Firpo JJ, Reiss E. Evidence for secondary hyperparathyroidism in idiopathic hypercalciuria. J Clin Invest 1973; 52: 134–142.
  • Coe FL, Favus MJ, Crockett T, Strauss AL, Parks JH, Porat A, Gantt CL, Sherwood LM. Effects of low-calcium diet on urine calcium secretion, parathyroid function and serum 1,25(OH)2D3 levels in patients with idiopathic hypercalciuria and in normal subjects. Am J Med 1982; 72: 25–32.
  • Danielson BG, Fellström B, Backman U, Holmgren K, Johansson G, Lindsjö M, Ljunghall S, Wikström B. Glycosaminoglycans and renal stone disease: Clinical effects of pentosanpolysulphate (Elmiron). Fortschr Urol Nephrol 1986; 25: 345–346.
  • Dowling RH, Rose GA, Sutor DJ. Hyperoxaluria and renal calculi in ileal disease. Lancet 1971; i: 1103–1106.
  • Earnest DL, Johnson G, Williams HE, Admirand WH. Hyperoxaluria in patients with ileal resection, and abnormality in dietary oxalate absorption. Gastroenterology 1974; 66: 1114–1122.
  • Earnest DL, Williams HE, Admirand WH. Treatment of enteric hyperoxaluria with calcium and medium chain triglycerides. Clin Res 1975; 23: 130 (abstract).
  • Habener JF, Rosenblatt M, Potts JTJr. Parathyroid hormone: biochemical aspects of biosynthesis, secretion, action and metabolism. Physiol Rev 1984; 64: 985–1083.
  • Henriquez-La Roche C, Rodriguez-Iturbe B, Herrera J, Parra G. Increased urinary excretion of prostaglandin E in patients with idiopathic hypercalciuria. Clin Sci 1988; 75: 581–587.
  • Hocking MP, Duerson MC, O'Leary P, Woodward ER. Jejunoileal bypass for morbid obesity. N Engl J Med 1983; 308: 995–999.
  • Kasidas GP, Rose GA. Removal of ascorbate from urine prior to assaying with a commercial kit. Clin Chim Acta 1987; 164: 215–221.
  • Kilander AF, Dotevall G, Fällström FP, Gillberg RE, Nilsson LO, Tarkowski A. Evaluation of gliadin antibodies for detection of coeliac disease. Scand J Gastroenterol 1983; 18: 377–383.
  • Lindsjö M, Danielson BG, Fellström B, Lithell H, Ljunghall S. Intestinal absorption of oxalate and calcium in patients with jejunoileal bypass. Scand J Urol Nephrol 1989; 23 283–289.
  • Lindsjö M, Danielson BG, Fellström B, Ljunghall S. Intestinal oxalate and calcium absorption in recurrent renal stone formers and healthy subjects. Scand J Urol Nephrol 1989; 23: 55–59.
  • Lindsjö M, Fellström B, Danielson BG, Kasidas GP, Rose GA, Ljunghall S. Hyperoxaluria or hypercalciuria in nephrolithiasis—the importance of renal tubular functions. Europ J Clin Invest 1990; 20: 546–554.
  • Ljunghall S, Backman U, Danielson BG, Fellström B, Johansson G, Wikström B. Calcium metabolism in renal stone disease. Scand J Urol Nephrol 1980; Suppl 53: 111–120.
  • Ljunghall S, Backman U, Danielson BG, Fellström B, Johansson G, Wikström B. Prophylactic treatment of renal calcium stones. Experiences with dietary advice, cellulose phosphate and thiazides. Scand J Urol Nephrol 1980; Suppl 53: 239–248.
  • Ljunghall S, Backman U, Danielson BG, Johansson G, Jung B, Källsen R, Wibell L, Wålinder O. Mechanisms of hypercalciuria in recurrent renal stone formers. Scand J Urol Nephrol 1977; Suppl 41: 77–96.
  • Muldowney FP, Freaney R, McMullin JP, Towers RP, Spillane A, O'Connor P, O'Donoghue P, Moloney M. Serum ionized calcium and parathyroid hormone in renal stone disease. Q J Med 1976; 45: 75–86.
  • Muldowney FP, Freaney R, Ryan JG. The pathogenesis of idiopathic hypercalciuria: Evidence of renal tubular calcium leak. Q J Med 1980; 49: 87–94.
  • Nordin BEC, Peacock M, Marshall DH. Calcium excretion and hypercalciuria. In: Fleisch H, Robertson WG, Smith LH, Vahlensieck W, eds. Urolithiasis research. New York: Plenum Press, 1976; 101–106.
  • Nussbaum SR, Zahradnik RJ, Lavigne JR, Brennan GL, Nozawa-Ung K, Kim LY, Keutmann GT, Wang CA, Potts JJr, Segre GV. Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. Clin Chem 1987; 33: 1364–1367.
  • Olthuis FMFG, Markslag AMG, Klein Elhorst JT, Krugers Dagneaux PGLC. Urinary oxalate estimation. Clin Chim Acta 1977; 75: 123–128.
  • Pak CYC. Physiological basis for absorptive and renal hypercalciurias. Am J Physiol 1979; 237: F415–F423.
  • Pak CYC, Ohata M, Lawrence EC, Snyder W. The hypercalciurias. J Clin Invest 1974; 54: 387–400.
  • Parfitt AM. Bone and plasma calcium homeostasis. Bone 1987; 8, Suppl 1: S1–S8.
  • Parkinson JD, Sheldon WL, Laker MF, Smith PA. Critical evaluation of a commercial enzyme kit (Sigma) for determining oxalate concentrations in urine. Clin Chem 1987; 33: 1203–1207.
  • Smith LH, Fromm H, Hofmann AF. Acquired hyperoxaluria, nephrolithiasis and intestinal disease. N Engl J Med 1972; 286: 1371–1375.
  • Stauffer JQ. Hyperoxaluria and intestinal disease. The role of steatorrhea and dietary calcium in regulating intestinal oxalate absorption. Digest Dis 1977; 22: 921–928.
  • Talmage RV, Grubb SA, Norimatsu H, Vander-Wiel CJ. Evidence for an important physiological role for calcitonin. Proc Natl Acad Sci USA 1980; 77: 609–613.
  • Tiselius HG, Ahlstrand C, Lundström B, Nilsson MA. [14C]-oxalate absorption by normal persons, calcium oxalate stone formers and patients with surgically disturbed intestinal function. Clin Chem 1981; 27: 1682–1685.
  • Wikström B, Backman U, Danielson BG, Fellström B, Johansson G, Ljunghall S. Ambulatory diagnostic evaluation of 389 recurrent renal stone formers. Klin Wochenschr 1983; 61: 85–90.
  • Wikström B, Backman U, Danielson BG, Fellström B, Johansson G, Ljunghall S, Wide L. Long-term phosphate treatment in calcium urolithiasis. In: Cohn DV, Potts JTJr.Fujita T, eds. Endocrine control of bone and calcium metabolism. Vol. 8B. Amsterdam: Elsevier Science Publ., 1984: 136–137.
  • Wikström B, Backman U, Danielson BG, Fellström B, Johansson G, Ljunghall S, Wide L. Phosphate metabolism in renal stone formers: Relation to renal tubular functions and calcium metabolism. Scand J Urol Nephrol 1981; Suppl 61: II 1–26.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.